PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹91 Cr | ₹18 Cr | ₹-186 Cr | ₹376 Cr | ₹835 Cr |
What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹376 Cr |
| Mar2021 | ₹835 Cr |
How is Consolidated Net Profit of PIRAMAL PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹91 Cr | 411.39 | |
| Mar2024 | ₹18 Cr | Positive | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹376 Cr | -54.98 | |
| Mar2021 | ₹835 Cr | - | |
Compare Consolidated Net Profit of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,240.6 Cr | -5% | 17.5% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -5% |
17.5% |
-24.7% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses